DanielCaseyMD

Family Medicine • Marlton, NJ

Professor, Psychiatry, Oregon Health and Science University School of Medicine

Join to view full profile

Dr. Casey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Casey's full profile

Already have an account?

Office
534 Lippincott Dr
Marlton, NJ 08053
Phone+1 856-985-7373

Fax+1 856-985-9611
Is this information wrong?

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Family Medicine, 2002 - 2005
Albany Medical CollegeClass of 2002

Certifications & Licensure

NJ State Medical License 2007 - 2025
OR State Medical License 1976 - 2017
PA State Medical License 2002 - 2008
American Board of Family Medicine Family Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015

Publications & Presentations

PubMed

21 citations
Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) ...
Jack J. Blanchard, Kristen Bradshaw, Cristina Garcia, Henry A. Nasrallah, Philip D. Harvey, Daniel E. Casey, Csilla Csoboth, James I. Hudson, Laura Julian, Ellen Lentz...> ;Schizophrenia Research. 2017 Jul 1
18 citations
The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: A focus on patients, caregivers, illness severity, functional status, disease burden and health...
Henry A. Nasrallah, Philip D. Harvey, Daniel E. Casey, Csilla Csoboth, James I. Hudson, Laura Julian, Ellen Lentz, Keith H. Nuechterlein, Diana O. Perkins, Nirali Koto...> ;Schizophrenia Research. 2015 Aug 1
7 citations
Response and remission rates with adjunctive aripiprazole in patients with major depressive disorder who exhibit minimal or no improvement on antidepressant monotherapy
Daniel E. Casey, Kimberly K. Laubmeier, James M. Eudicone, R. Marcus, Robert M. Berman, Zia Rahman, John J. Sheehan> ;International Journal of Clinical Practice. 2014 Nov 1
25 citations
A Double-Blind Randomized Trial of Mood Stabilizer Augmentation Using Lamotrigine and Valproate for Patients With Schizophrenia Who Are Stabilized and Partially Respon...
Ira D. Glick, Jeane Bosch, Daniel E. Casey> ;Journal of Clinical Psychopharmacology. 2009 Jun 1
39 citations
Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia
Daniel E. Casey, David G. Daniel, Carol A. Tamminga, John M. Kane, Tram Tran-Johnson, Patricia Wozniak, Walid M. Abi-Saab, Jeff Baker, Laura Redden, Nicholas Greco, Ma...> ;Neuropsychopharmacology. 2009 Apr 1
49 citations
Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, do...
Daniel E. Casey, Earl E. Sands, J. Heisterberg, Hwa Ming Yang> ;Psychopharmacology. 2008 Jul 4
218 citations
ACNP White Paper: Update on Use of Antipsychotic Drugs in Elderly Persons with Dementia
Dilip V. Jeste, Dan G. Blazer, Daniel E. Casey, Thomas W. Meeks, Carl Salzman, Lon S. Schneider, Pierre N. Tariot, Kristine Yaffe> ;Neuropsychopharmacology. 2008 Apr 1
52 citations
Comparison of Metabolic Syndrome Incidence Among Schizophrenia Patients Treated With Aripiprazole Versus Olanzapine or Placebo
Gilbert L'Italien, Daniel E. Casey, H. Kan, William H. Carson, Ronald N. Marcus> ;The Journal of Clinical Psychiatry. 2007 Oct 15
39 citations
Implications of the CATIE trial on treatment: extrapyramidal symptoms.
Daniel E. Casey> ;CNS Spectrums. 2006 Jul 1
760 citations
Schizophrenia and increased risks of cardiovascular disease.
Charles H. Hennekens, Alissa R. Hennekens, Danielle Hollar, Daniel E. Casey> ;American Heart Journal. 2005 Dec 1
89 citations
Antipsychotic drug-induced weight gain: development of an animal model
Mark B. Cope, Tim R. Nagy, Jose R. Fernandez, N Geary, Daniel E. Casey, David B. Allison> ;International Journal of Obesity. 2005 Jun 1
133 citations
Metabolic issues and cardiovascular disease in patients with psychiatric disorders.
Daniel E. Casey> ;The American Journal of Medicine. 2005 Apr 1
77 citations
Dyslipidemia and atypical antipsychotic drugs.
Daniel E. Casey> ;The Journal of Clinical Psychiatry. 2004 Dec 15
55 citations
Metabolic effects of treatment with atypical antipsychotics.
John M. Kane, Eugene J. Barrett, Daniel E. Casey, Christoph U. Correll, Alan J. Gelenberg, Samuel Klein, John W. Newcomer> ;The Journal of Clinical Psychiatry. 2004 Nov 1
556 citations
Physical Health Monitoring of Patients With Schizophrenia
Stephen R. Marder, Susan M. Essock, Alexander L. Miller, Robert W. Buchanan, Daniel E. Casey, John M. Davis, John M. Kane, Jeffrey A. Lieberman, Nina R. Schooler, Nanc...> ;The American Journal of Psychiatry. 2004 Aug 1
117 citations
Pathophysiology of antipsychotic drug-induced movement disorders.
Daniel E. Casey> ;The Journal of Clinical Psychiatry. 2004 May 1
80 citations
Adjunctive Divalproex and Hostility Among Patients With Schizophrenia Receiving Olanzapine or Risperidone
Leslie Citrome, Daniel E. Casey, David G. Daniel, Patricia Wozniak, Lisa D. Kochan, Katherine A. Tracy> ;Psychiatric Services. 2004 Mar 1
5 citations
Unbalanced statistical analysis of combined divalproex and antipsychotic therapy for schizophrenia.
Laura S. Boylan, Daniel L. Labovitz, Daniel E. Casey, David G. Daniel, Adel A. Wassef, Katherine A. Tracy, Patricia Wozniak, Kenneth W. Sommerville> ;Neuropsychopharmacology. 2004 Mar 1
274 citations
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Daniel E. Casey, Dan W. Haupt, John W. Newcomer, David C. Henderson, Michael J. Sernyak, Michael Davidson, Jean-Pierre Lindenmayer, Steven V. Manoukian, Mary Ann Baner...> ;The Journal of Clinical Psychiatry. 2004 Jan 1
6 citations
Long-term treatment goals: enhancing healthy outcomes
Daniel E. Casey> ;CNS Spectrums. 2003 Nov 1
72 citations
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial
Steven G. Potkin, Larry Alphs, Chuanchieh Hsu, K. Ranga Rama Krishnan, Ravi Anand, Frederick Young, Herbert Y. Meltzer, Alan I. Green, Saide Altinsan, Siemion Altman, ...> ;Biological Psychiatry. 2003 Aug 15
191 citations
Switching Patients to Aripiprazole From Other Antipsychotic Agents: A Multicenter Randomized Study
Daniel E. Casey, William H. Carson, A. Saha, Amy Liebeskind, Mirza Ali, Darlene Jody, Gary G. Ingenito> ;Psychopharmacology. 2003 Feb 28
848 citations
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
Herbert Y. Meltzer, Larry Alphs, Alan I. Green, A. Carlo Altamura, Ravi Anand, Alberto Bertoldi, Marc Bourgeois, Guy Chouinard, M. Zahur Islam, John M. Kane, Ranga Kri...> ;Archives of General Psychiatry. 2003 Jan 1
2 citations
Effect of a novel potential atypical antipsychotic drug, Y-931, in producing dystonia in Cebus monkeys
Yasuyuki Shiigi, Jun Ichi Maeda, Hiroshi Yasumatsu, Hiroshi Tanaka, Daniel E. Casey> ;Journal of Pharmacological Sciences. 2003 Jan 1
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.
Casey DE, Daniel DG, Wassef AA, Tracy KA, Wozniak P, Sommerville KW> ;Neuropsychopharmacology. 2003-01-01
Join now to see all

Hospital Affiliations

Virtua MarltonMarlton, New Jersey